Frequency of Microalbuminuria in Stages of Chronic Kidney Disease
Abstract
Objective: To investigate the frequency of microalbuminuria and associated risk factors across the stages of chronic kidney disease (CKD).
Methods: This cross-sectional study included 200 patients aged 16-85 who applied to the Internal Medicine Outpatient Clinic between November 2009 and February 2010. Demographic data and blood pressure were recorded. Biochemical parameters, along with 24-hour urinary protein and albumin excretion, were measured. CKD staging was performed according to GFR calculated using the MDRD formula.
Results: Of the patients, 64% were female. The most common etiology was undetermined (58%). Among identified causes, diabetes mellitus and hypertension were primary. As the CKD stage progressed, proteinuria and albuminuria levels increased significantly (p<0.001). The frequency of microalbuminuria was 23.1% in Stage 1 and reached 80% in Stage 5. Significant associations were found between CKD stages and blood pressure, urea, creatinine, potassium, calcium, hemoglobin, and CRP levels (p<0.05). Proteinuria and albuminuria showed a negative correlation with GFR and a positive correlation with CRP (p<0.001).
Conclusion: Microalbuminuria appears from the early stages of CKD, and its frequency increases as the disease progresses. Hypertension and inflammation (elevated CRP) are independent risk factors associated with microalbuminuria. Screening CKD patients for microalbuminuria from the early stages is crucial for slowing disease progression.
Keywords
Chronic kidney disease, Microalbuminuria, Proteinuria, CRP, Hypertension
Ethical Statement
References
- 1. Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis. 1996;27(6):765- 75. doi:10.1016/S0272-6386(96)90512-0.
- 2. Hirschberg R, Wang S. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease. Curr Opin Nephrol Hypertens. 2005;14(1):43-52. doi:10.1097/00041552-200501000-00008.
- 3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;319(8287):1430-2. doi:10.1016/S0140- 6736(82)92450-3.
- 4. Kaplan NM. Microalbuminuria: a risk factor for vascular and renal complications of hypertension. Am J Med. 1992;92(4-Suppl 2):S9-12. doi:10.1016/0002- 9343(92)90141-W.
- 5. Winocour PH. Microalbuminuria. BMJ. 1992;304(6836):1196-7. doi:10.1136/bmj.304.6836.1196.
- 6. Erdmann E. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Int J Cardiol. 2006;107(2):147-53. doi:10.1016/j.ijcard.2005.03.053.
- 7. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157(13):1413-8. doi:10.1001/ archinte.1997.00440340025002.
- 8. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310(6):356-60. doi:10.1056/ NEJM198402093100605.
- 9. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int. 2006;69(7):1189-97. doi:10.1038/ sj.ki.5000212.
- 10. Gansevoort RT, de Zeeuw D, de Jong PE. Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant. 1995;10(4):497-504. doi:10.1093/ndt/10.4.497.